A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
Recruiting · NCT06644118 · Registry updated 2024-11-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 1 | 2024-11-08 | NCT06644118 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Overland Therapeutics | 2 |
| Zhejiang University | 194 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Gobroad Boren Hospital | Beijing | China | 1 |
| The Affiliated Hospital of Northwest University Xi'an No.3 Hospital | Xi’an | China | 1 |
| The first affiliated hospital, College of Medicine, Zhejiang University | Hangzhou | China | 1 |